These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 2940212)

  • 1. Cephalosporins, vancomycin, aminoglycosides and other drugs, especially in combination, for the treatment of methicillin-resistant staphylococcal infections.
    Klastersky J; Van der Auwera P
    J Antimicrob Chemother; 1986 Mar; 17 Suppl A():19-24. PubMed ID: 2940212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro susceptibility of methicillin-resistant Staphylococcus aureus to imipenem and other antimicrobial agents.
    Ishag AJ; Durgham SM; Shibl AM
    Chemioterapia; 1987 Aug; 6(4):261-3. PubMed ID: 3477333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of infections due to methicillin-resistant Staphylococcus aureus.
    Waldvogel FA
    J Hosp Infect; 1986 Mar; 7 Suppl A():37-46. PubMed ID: 2871096
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro activity of fosfomycin combined with rifampin, pefloxacin and imipenem against staphylococci: a study by the time-kill curve method.
    Quentin C; Saivin S; Lafferriere C; Noury P; Bebear C
    Drugs Exp Clin Res; 1987; 13(4):219-24. PubMed ID: 3476291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on prevalence and treatment of methicillin-resistant Staphylococcus aureus infections.
    Loffler CA; Macdougall C
    Expert Rev Anti Infect Ther; 2007 Dec; 5(6):961-81. PubMed ID: 18039081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Teicoplanin, vancomycin, rifampicin: in-vivo and in-vitro studies with Staphylococcus aureus.
    Carper HT; Sullivan GW; Mandell GL
    J Antimicrob Chemother; 1987 May; 19(5):659-62. PubMed ID: 2956229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro combined bactericidal activity of cefpirome and glycopeptides against glycopeptides and oxacillin-resistant staphylococci.
    Bergeret M; Boutros N; Raymond J
    Int J Antimicrob Agents; 2004 Mar; 23(3):247-53. PubMed ID: 15164965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro study of the potential role of quinupristin/dalfopristin in the treatment of catheter-related staphylococcal infections.
    Garcia R; Raad I
    Eur J Clin Microbiol Infect Dis; 1996 Dec; 15(12):933-6. PubMed ID: 9031876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro evaluation of antibiotics' combinations for empirical therapy of suspected methicillin resistant Staphylococcus aureus severe respiratory infections.
    Drago L; De Vecchi E; Nicola L; Gismondo MR
    BMC Infect Dis; 2007 Sep; 7():111. PubMed ID: 17888153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of teicoplanin in localized experimental infections in rats.
    Arioli V; Berti M; Candiani G
    J Hosp Infect; 1986 Mar; 7 Suppl A():91-9. PubMed ID: 2871103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antistaphylococcal activity of teicoplanin in Riyadh, Saudi Arabia.
    Shibl AM; Ishag AH; Durgham SM
    APMIS Suppl; 1988; 3():68-70. PubMed ID: 2972301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Teicoplanin compared with vancomycin for treatment of experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis.
    Galetto DW; Boscia JA; Kobasa WD; Kaye D
    J Infect Dis; 1986 Jul; 154(1):69-75. PubMed ID: 2940303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vancomycin therapy of severe staphylococcal infections.
    Kirby WM
    J Antimicrob Chemother; 1984 Dec; 14 Suppl D():73-8. PubMed ID: 6394579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Methicillin resistant staphylococci].
    Afanas'eva TI
    Antibiot Khimioter; 1998; 43(6):29-31. PubMed ID: 9644532
    [No Abstract]   [Full Text] [Related]  

  • 15. Anti-staphylococcal activity of teicoplanin, vancomycin, and other antimicrobial agents: the significance of methicillin resistance.
    Del Bene VE; John JF; Twitty JA; Lewis JW
    J Infect Dis; 1986 Aug; 154(2):349-52. PubMed ID: 2941491
    [No Abstract]   [Full Text] [Related]  

  • 16. Emergence and spread of rifampicin-resistant, methicillin-resistant Staphylococcus aureus during vancomycin-rifampicin combination therapy in an intensive care unit.
    Ju O; Woolley M; Gordon D
    Eur J Clin Microbiol Infect Dis; 2006 Jan; 25(1):61-2. PubMed ID: 16331332
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of infections due to methicillin-resistant Staphylococcus aureus.
    Watanakunakorn C
    Ann Intern Med; 1982 Sep; 97(3):376-8. PubMed ID: 7114635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of dalbavancin and telavancin against staphylococci and streptococci isolated from patients in Canadian hospitals: results of the CANWARD 2007-2009 study.
    Karlowsky JA; Adam HJ; Poutanen SM; Hoban DJ; Zhanel GG;
    Diagn Microbiol Infect Dis; 2011 Mar; 69(3):342-7. PubMed ID: 21353963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bactericidal activity of oxacillin and glycopeptides against Staphylococcus aureus in patients with endocarditis: looking for a relationship between tolerance and outcome.
    Pasticci MB; Moretti A; Stagni G; Ravasio V; Soavi L; Raglio A; Vailati F; Cardaccia A; Santucci A; Papili R; Sgrelli A; Pallotto C; Baldelli F
    Ann Clin Microbiol Antimicrob; 2011 Jun; 10():26. PubMed ID: 21658248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative efficacy of pefloxacin and six other antimicrobial agents on Staphylococcus aureus experimental abscesses.
    Rolin O; Huet Y; Bouanchaud DH
    J Antimicrob Chemother; 1986 Apr; 17 Suppl B():49-52. PubMed ID: 2940215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.